Oxford launches new vaccine trial to enhance design of flu & COVID-19 vaccines

Published on October 25, 2023

This study will test the responses of cells in lymph nodes before and after immunisation with flu and COVID-19 vaccines and compare reactions in older and younger adults

 

  • The new study will measure how lymph nodes respond to vaccines and how this reaction changes as we age
  • Results will contribute to future vaccine design which will offer greater protection to those most vulnerable to diseases such as flu and COVID-19 and also those better suited for younger people
  • Project to be led by Principal Investigator Dr Katrina Pollock, MRC Clinician Scientist in Vaccinology at the Oxford Vaccine Group, based at the Department of Paediatrics, at the University of Oxford
  • £1.95 million funding from the Medical Research Council/UK Research and Innovation, sponsored by the University of Oxford